1. A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient Stephen R. Ash, Bhupinder Singh, Philip T. Lavin, Fiona Stavros, Henrik S. Rasmussen Kidney International Volume 88, Issue 2, Pages 404-411 (August 2015) DOI: 10.1038/ki.2014.382 Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions

2. Figure 1 Kidney International 2015 88, 404-411DOI: (10.1038/ki.2014.382) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions

3. Figure 2 Kidney International 2015 88, 404-411DOI: (10.1038/ki.2014.382) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions

4. Figure 3 Kidney International 2015 88, 404-411DOI: (10.1038/ki.2014.382) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions

5. Figure 4 Kidney International 2015 88, 404-411DOI: (10.1038/ki.2014.382) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions

6. Figure 5 Kidney International 2015 88, 404-411DOI: (10.1038/ki.2014.382) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions

7. Figure 6 Kidney International 2015 88, 404-411DOI: (10.1038/ki.2014.382) Copyright © 2015 International Society of Nephrology Terms and Conditions Terms and Conditions